The Size of the Medical Device Technology Market in the Middle East & Africa is expected to be worth USD 75.37 Mn by 2029 from USD 66.03 Mn in 2024, growing at a CAGR of 2.68% during the forecast period.
The improvement in technology has changed how medical instruments are utilized to treat patients. The new technologies have reduced the recovery time and cost of treatment for a patient. Medical devices range from small needles to large diagnostic machines. Some of these Technologies are the Mela Find optical instrument for the treatment of melanoma skin cancer, electronic aspirin used for relief from migraines, robotic health checkup instrument, needle-free diabetes care instrument to find the glucose level, and Sapien transcatheter aortic valve instrument used in open-heart surgery.
MRI Systems, Ultrasound systems, x-ray systems, and mammography instruments are on demand globally for the diagnosis of diseases and disorders. With the increasing demand for the above-mentioned instruments market device technology market will also increase. At present, many hospitals and clinics are adopting workflow automation processes to ensure patient safety. Workflow automation provides fast and consistent data analysis. The increased need for workflow automation and better communication processes are also major driving factors in the medical device industry.
With the growing occurrence of technology piracy, it is hard to avert the misuse of non-licensed technology in biomedical device integration. This is a major restraint for the medical device technology industry. Technical complexity and the high cost of some medical technology might restrict global market demand. In addition regulatory compliance for approval of medical device, technology is a major factor that might hinder the global market for medical device technology. This region has the lowest CAGR and is growing slowly because of a lack of market strength and advanced technology.
Key Market Companies dominating the Middle East & Africa Medical Device Technologies Market Profiled in the Report are Abbott Laboratories, Inc., Becton, Dickinson and Company, GE Healthcare, Novartis Diagnostics, bioMerieux, Inc., Biomerica, Inc., Johnson and Johnson Diagnostics, Inc., Olympus Corporation, Qiagen N.V., Siemens AG, Thermo Fischer Scientific, Inc., and Zenith Healthcare Ltd.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1600
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region